Details of the Drug Reposition

General Information of This Drug (ID: DMJ1NG4)

Drug Name
Dalazatide   DMJ1NG4
Synonyms
Dalazatide [INN]; UNII-6U0259J807; 1081110-69-1; o-PHOSPHONO-L-Tyrosyl-2-(2-(2-aminoethoxy)ethoxy)acetyl(potassium channel toxin kappa-stichotoxin-shela stoichactis helianthus (caribbean sea anemone)) peptidamide; 6U0259J807
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1b/2a Indication(s)
Indication Name Indication ID ICD-11 Status REF
Inclusion body myositis DISZXXG5 4A41.2 Phase 1b/2a [1]
Psoriasis vulgaris DIS6M7AN EA90 Phase 1b/2a [1]
------------------------------------------------------------------------------------

References

1 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.